Belluscura remains confident despite big jump in half-year losses
"I am very pleased with the substantial operational progress the group has made since the launch of our first product in September last year,” said CEO Bob Rauker
Sector
Health
989 stories · page 28 of 50
Wellbeing Digital Sciences posts fiscal 4Q results; projects significant revenue from research and consulting contracts
For the quarter ended July 31, 2022, the company posted revenue of C$1,160,547, up from $1,131,171 in the year-ago period
Braxia Scientific launches KetaMD as first Florida patients complete initial virtual ketamine treatments at home
"We are working on scaling KetaMD beyond Florida across the US, opening up the opportunity for people to receive care any time, from the comfort of their own homes," said KetaMD CEO Warren Gumpel
Wellteq Digital Health licenses top-performing electronic Cognitive Behavioural Therapy (eCBT) program
"These coordinated regimes at scale can dramatically reduce the incidence and impact of an estimated US$8 trillion of preventable healthcare costs globally,” Wellteq Digital Health CEO Scott Montgomery said
Irwin Naturals Emergence mental-health clinic chain set to expand with ketamine clinic in Ohio
The company has struck a binding deal to acquire, in cash and shares, all of the membership interests in Happier You LLC, which operates a ketamine clinic in central Ohio
Wellteq Digital Health agrees to acquisition by Australia's Advanced Human Imaging
Under the arrangement, Wellteq said its shareholders will receive one ordinary share of Advanced Human Imaging (AHI) for every six Wellteq shares or 0.1667 AHI shares for every 1 Wellteq share
Irwin Naturals inks licensing deal to produce and distribute its THC products in Michigan
“Michigan is a significant step in what is becoming a sprint to put Irwin Naturals THC products on the shelves of dispensaries in all 38 states where cannabis is legalized,” Irwin Naturals CEO Klee Irwin said
Irwin Naturals execs plot course for nutraceutical sales growth, ketamine clinic rollout in 2Q results
Irwin Naturals intends to leverage its brand status to drive an aggressive rollout of mental health clinics, namely ketamine clinics
Braxia Scientific posts 13% rise in Q1 revenue; launches KetaMD in US
"We are proud to have launched KetaMD in the US so that we can begin addressing the needs of millions lacking access to innovative treatments for mental health disorders such as depression, anxiety, bipolar disorder and post-traumatic stres
PharmaDrug aims to file provisional patent for treatment of glaucoma in the fourth quarter this year
The firm said it has selected a final lead drug candidate from a short list of six DMT analogues and intends to submit the patent in the fourth quarter this year
Pathway Health reports improved quarter-over-quarter revenue driven by easing COVID-19 restrictions
The Canadian medical cannabis service provider saw revenues improved quarter-over-quarter after pandemic restrictions were eased
Wellbeing Digital Sciences says subsidiary KGK Sciences wins FDA's highest safety rating for ProGo ingredient on behalf of client Hofseth BioCare
The FDA's no-objection acknowledgement letter is the highest safety rating and attestation the client can achieve for its dietary ingredient, Wellbeing Digital Sciences said
Wellbeing Digital Sciences says subsidiary IRP Health’s new Toronto clinic has received approval from Veterans Affairs Canada for its Reactivation program
IRP Health's Reactivation program hopes to reduce patient disability in the short and long term, while giving veterans better control and understanding of their pain and health challenges
Empower Clinics says it will divest two TMC clinics following operational review
"After analyzing the operations of our TMC clinics and taking into consideration the potential for future growth, we've decided that both Hamilton and Mississauga clinics do not fully meet our expansion goals", Steven McAuley, chairman and
Wellbeing Digital Science says KGK subsidiary to unlock $17M in future revenue by completing contracts in next 12-18 months
“We believe focusing on expanding our network of clinics will provide the company with a larger footprint to roll out new treatments as they become approved by the Food and Drug Administration and Health Canada,” said Wellbeing CEO Najla Gu
IQ-AI mulls 'de novo' route for MRI device
The de novo pathway is specifically designed for novel medical devices
Irwin Naturals acquires Vermont ketamine treatment clinic to expand national footprint
“We’re moving fast right now to take advantage of this opportunity to be the first national brand in this space, establishing ourselves as the first name people will think of when it comes to receiving these life-changing treatments,” Irwin
Irwin Naturals completes Georgia acquisition and adds two ketamine clinics to national chain
“The vision we laid out for Irwin Naturals Emergence is becoming a reality with each acquisition we announce and execute,” said Irwin Naturals CEO Klee Irwin
Irwin Naturals inks exclusive licensing deal with Entourage Health to produce and distribute cannabis products in Canada
The nutraceutical company said Entourage will manufacture the newly-formulated suite of Irwin-branded line of softgels in five different varieties: CBD, THC and three additional formulations that include both THC and another cannabinoid
Pathway Health appoints healthcare veteran Dr Rakesh Jetly to its board of directors
“We are excited to welcome Dr Jetly to our board of directors and look forward to leveraging his expertise and insights in mental health as we continue to expand the services offered to our patients,” Pathway Health CEO Ken Yoon said